Mona Khalid

Mona Khalid is an accomplished professional with extensive experience in portfolio strategy, health economics, outcomes research, and epidemiology. Khalid's most recent positions include Vice President at ENDPOINT HEALTH, where responsibilities spanned portfolio strategy and scientific affairs, as well as value demonstration and patient access. Prior to this, Khalid served as Vice President at Galapagos and held consulting roles in outcomes, access, and epidemiology. Additional roles at Takeda included Global Head of Evidence and Value Generation. Khalid's educational background includes a PhD in Epidemiology from University College London, an MSc in Biomedical Sciences from St George's, University of London, and a BSc (Hons) in Science from the University of Waterloo. Advanced management training was obtained from Harvard Business School and the MIT Sloan School of Management.